Review
Pharmacological breast cancer therapy (review)
Affiliations
- PMID: 16211230
Item in Clipboard
Review
Pharmacological breast cancer therapy (review)
Int J Oncol.
2005 Nov.
Abstract
Breast cancer ranks as the second most common cause of cancer death among women in the United States. Anticancer agents are an important component of breast cancer therapy. Drugs frequently used to treat breast cancer include methotrexate, 5-fluorouracil (5-FU), cyclophosphamide, anthracyclines, taxanes, trastuzumab, tamoxifen, and aromatase inhibitors. These agents inhibit breast cancer progression by a variety of different mechanisms. This review describes each of these drugs and the varying effects each of them have upon breast cancer cells.
Similar articles
-
Combining chemo-, hormonal and targeted therapies to treat breast cancer (Review).Mol Med Rep. 2008 Mar-Apr;1(2):139-60. Mol Med Rep. 2008. PMID: 21479390
-
[Medical treatment of early breast cancer: chemotherapy].Ugeskr Laeger. 2007 Sep 10;169(37):3070-2. Ugeskr Laeger. 2007. PMID: 17877950 Danish.
-
Aromatase inhibitors and breast cancer.Minerva Endocrinol. 2006 Mar;31(1):27-46. Minerva Endocrinol. 2006. PMID: 16498362 Review.
-
The use of third-generation aromatase inhibitors and tamoxifen in the adjuvant treatment of postmenopausal patients with hormone-dependent breast cancer: evidence based review.Curr Opin Oncol. 2007 Nov;19(6):564-72. doi: 10.1097/CCO.0b013e3282f1c523. Curr Opin Oncol. 2007. PMID: 17906453 Review.
-
New agents in development for breast cancer.Curr Opin Obstet Gynecol. 2007 Feb;19(1):68-74. doi: 10.1097/GCO.0b013e328011e6a2. Curr Opin Obstet Gynecol. 2007. PMID: 17218855 Review.
Cited by
-
Effects of American ginseng on pharmacokinetics of 5-fluorouracil in rats.Biomed Chromatogr. 2015 May;29(5):762-7. doi: 10.1002/bmc.3354. Epub 2014 Oct 22. Biomed Chromatogr. 2015. PMID: 25339249 Free PMC article.
-
Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.Oncotarget. 2014 Jul 15;5(13):4603-50. doi: 10.18632/oncotarget.2209. Oncotarget. 2014. PMID: 25051360 Free PMC article. Review.
-
Inhibition of GSK-3β activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cells.Cell Cycle. 2014;13(5):820-33. doi: 10.4161/cc.27728. Epub 2014 Jan 9. Cell Cycle. 2014. PMID: 24407515 Free PMC article.
-
Influence of 5-fluorouracil on ferredoxin reductase mRNA splice variants in colorectal carcinomas.Oncol Lett. 2010 Mar;1(2):351-354. doi: 10.3892/ol_00000062. Epub 2010 Mar 1. Oncol Lett. 2010. PMID: 22966307 Free PMC article.
-
Involvement of Akt-1 and mTOR in sensitivity of breast cancer to targeted therapy.Oncotarget. 2011 Jul;2(7):538-50. doi: 10.18632/oncotarget.302. Oncotarget. 2011. PMID: 21730367 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
